← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2017Last known activity
May 4, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 19 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT07227909CollaboratorPhase 2May 4, 2026
- NCT07251491CollaboratorPhase 1/Phase 2Jan 1, 2026
- NCT07053917CollaboratorPhase 1Dec 31, 2025
- NCT06512194CollaboratorPhase 2Feb 28, 2025
- NCT06888128CollaboratorPhase 2Jan 30, 2025
- NCT06430541CollaboratorPhase 1Dec 31, 2024
- NCT06442423CollaboratorPhase 1Oct 17, 2024
- NCT06308653Lead sponsorPhase 3Mar 5, 2024
- NCT05592379CollaboratorPhase 1Mar 31, 2023
- NCT05557643CollaboratorEarly Phase 1Jan 1, 2023
- NCT05399498CollaboratorPhase 2Dec 31, 2022
- NCT05698095Lead sponsorPhase 1Dec 27, 2022
- NCT05478278Lead sponsorPhase 1Jun 22, 2022
- NCT04950608CollaboratorPhase 2Nov 30, 2021
- NCT05029466CollaboratorPhase 2Nov 19, 2021
Details
- Last known activity
- May 4, 2026